Latest total assets for ALNA: $18M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Allena Pharmaceuticals (ALNA) currently reports a total assets of $18M as of June 2022. That compares with $30M in the prior-year period — down 41.2% year over year. Use the charts on this page to explore Allena Pharmaceuticals's total assets history and peer comparisons.
Allena Pharmaceuticals's total assets decreased from $30M to $18M — a 41.2% year-over-year decrease (period ending June 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Allena Pharmaceuticals reported $18M in total assets as of June 2022. That compares with $30M in the prior-year period — down 41.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current total assets of $18M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Allena Pharmaceuticals, and consider following ALNA for alerts when major investors trade the stock.
Allena Pharmaceuticals is classified in the Healthcare sector. On total assets, it currently shows $18M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ALNA with unrelated industries.